Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PRECIGEN, INC. | 1,000,000 | reported | 22 Sept 2016 | tx 3+4,000,000 |
| PFIZER INC | 120,805 | reported | 26 Feb 2015 | tx 73+1,779,142−275,250 |
| Entera Bio Ltd. | 40,000 | reported | 09 Mar 2026 | tx 2+40,000 |
| Harmony Biosciences Holdings, Inc. | 21,231 | reported | 14 May 2026 | tx 1+21,231 |
| Zoetis Inc. | 5,000 | reported | 06 Feb 2013 | tx 1+5,000 |
| WYETH | 0 | reported | 15 Oct 2009 | tx 22+62,640−324,561.01 |
| PRECISION BIOSCIENCES INC | 0 | reported | 20 May 2026 | tx 15+463,311−35,028 |
| MEDICINES CO /DE | 0 | reported | 06 Jan 2020 | tx 9+52,223−52,223 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 12+129,708−21,500 |
| Bioverativ Inc. | 0 | reported | 08 Mar 2018 | tx 4+27,184−27,184 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | EXERCISE | PRECISION BIOSCIENCES INC | 21,000 | — | |
| 20 May 2026 | EXERCISE | PRECISION BIOSCIENCES INC | 21,000 | 0.00 USD | deriv |
| 14 May 2026 | GRANT_AWARD | Harmony Biosciences Holdings, Inc. | 21,231 | 0.00 USD | deriv |
| 09 Mar 2026 | PURCHASE | Entera Bio Ltd. | 20,000 | 1.30 USD | |
| 10 Feb 2026 | PURCHASE | Entera Bio Ltd. | 20,000 | 1.49 USD | |
| 16 Dec 2025 | PURCHASE | PRECISION BIOSCIENCES INC | 3,000 | 4.72 USD | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 21,500 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 21,500 | 0.00 USD | deriv |
| 27 May 2025 | EXERCISE | PRECISION BIOSCIENCES INC | 9,826 | — | |
| 27 May 2025 | EXERCISE | PRECISION BIOSCIENCES INC | 9,826 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 21,000 | 0.00 USD | deriv |
| 25 Mar 2025 | PURCHASE | PRECISION BIOSCIENCES INC | 3,250 | 5.30 USD | |
| 30 Dec 2024 | PURCHASE | PRECISION BIOSCIENCES INC | 3,605 | 4.49 USD | first after silence |
| 10 Jun 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 9,826 | 0.00 USD | deriv |
| 04 May 2024 | EXERCISE | PRECISION BIOSCIENCES INC | 4,202 | — | |
| 04 May 2024 | EXERCISE | PRECISION BIOSCIENCES INC | 4,202 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 04 May 2023 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 126,075 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 9,947 | 0.00 USD | deriv |
| 10 May 2022 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 156,951 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 10 May 2021 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 32,800 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 10 Mar 2020 | GRANT_AWARD | PRECISION BIOSCIENCES INC | 71,776 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Dec 2024.